Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Resource Type
- Authors
- Vassiliki Bravis; Felicity Kaplan; Claire L Meek; Abigail Don
- Source
- The Obstetrician & Gynaecologist. 15:171-176
- Subject
- Gynecology
Pediatrics
medicine.medical_specialty
Ethical issues
business.industry
media_common.quotation_subject
Hyperandrogenism
food and beverages
Fertility
Testosterone (patch)
medicine.disease
Polycystic ovary
Increased risk
medicine
Differential diagnosis
business
hirsutism
media_common
- Language
- ISSN
- 1467-2561
Key content The presence of clinical or biochemical evidence of hyperandrogenism is a defining feature of polycystic ovary syndrome (PCOS). As the criteria for diagnosing PCOS becomes more inclusive, there is an increased risk of misdiagnosing women with other causes of hyperandrogenism. Biochemical testing for serum testosterone concentrations in women has important limitations. Patients with concerning features should be investigated for other causes of hyperandrogenism. Learning objectives To review the different criteria for diagnosing PCOS and the repercussions for disease prevalence. To learn about the differential diagnosis of hyperandrogenism. To learn about the limitations of biochemical testing for testosterone in women. Ethical issues Hyperandrogenism causing hirsutism and virilisation can have significant effects on physical and psychological wellbeing. Misdiagnosis can delay appropriate treatment and may affect future fertility.